Aberrant methylation and silencing of IRF8 expression in non-small cell lung cancer

Oncology Letters

Volumn 8, Issue 3, 2014, Pages 1025-1030

  Suzuki, Makoto ^a   Ikeda, Koei ^a   Shiraishi, Kenji ^a   Eguchi, Ayami ^a   Mori, Takeshi ^a   Yoshimoto, Kentaro ^a   Shibata, Hidekatsu ^a   Ito, Takaaki ^a   Baba, Yoshifumi ^a   Baba, Hideo ^a  

^a KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Expression; IRF8; Methylation; Pyrosequencing

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; COMPLEMENTARY DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; INTERFERON CONSENSUS SEQUENCE BINDING PROTEIN; MESSENGER RNA;

ADENOCARCINOMA; ARTICLE; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER SPECIFIC SURVIVAL; CANCER STAGING; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PROTEIN EXPRESSION; PROTEIN METHYLATION; PYROSEQUENCING; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION;

EID: 84904265513     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2014.2234     Document Type: Article

References (18)

1. Kris MG, Benowitz SI, Adams S, Diller L, Ganz P, Kahlenberg MS, et al: Clinical cancer advances 2010: annual report on progress against cancer from the American Society of Clinical Oncology. J Clin Oncol 28: 5327-5347, 2010.
2. Suzuki M and Yoshino I: Aberrant methylation in non-small cell lung cancer. Surg Today 40: 602-607, 2010.
3. Yang D, Thangaraju M, Greeneltch K, Browning DD, Schoenlein PV, Tamura T, et al: Repression of IFN regulatory factor 8 by DNA methylation is a molecular determinant of apoptotic resistance and metastatic phenotype in metastatic tumor cells. Cancer Res 67: 3301-3309, 2007.
4. Tamura T, Yanai H, Savitsky D, Taniguchi T: The IRF family transcription factors in immunity and oncogenesis. Annual Rev Immunol 26: 535-584, 2008.
5. Lu R: Interferon regulatory factor 4 and 8 in B-cell development. Trends Immunol 29: 487-492, 2008.
6. Holtschke T, Lohler J, Kanno Y, Fehr T, Giese N, Rosenbauer F, et al: Immunodeficiency and chronic myelogenous leukemia-like syndrome in mice with a targeted mutation of the ICSBP gene. Cell 87: 307-17, 1996.
7. Burchert A, Cai D, Hofbauer LC, Samuelsson MK, Slater EP, Duyster J, et al: Interferon consensus sequence binding protein (ICSBP; IRF-8) antagonizes BCR/ABL and down-regulates bcl-2. Blood 103: 3480-3489, 2004.
8. Dror N, Rave-Harel N, Burchert A, Azriel A, Tamura T, Tailor P, et al: Interferon regulatory factor-8 is indispensable for the expression of promyelocytic leukemia and the formation of nuclear bodies in myeloid cells. J Biol Chem 282: 5633-5640, 2007.
9. Schmidt M, Nagel S, Proba J, Thiede C, Ritter M, Waring JF et al: Lack of interferon consensus sequence binding protein (ICSBP) transcripts in human myeloid leukemias. Blood 91: 22-29, 1998.
10. Liu K and Abrams SI: Coordinate regulation of IFN consensus sequence-binding protein and caspase-1 in the sensitization of human colon carcinoma cells to Fas-mediated apoptosis by IFN-gamma. J Immunol 170: 6329-6337, 2003.
11. Lee KY, Geng H, Ng KM, Yu J, van Hasselt A, Cao Y, et al: Epigenetic disruption of interferon-gamma response through silencing the tumor suppressor interferon regulatory factor 8 in nasopharyngeal, esophageal and multiple other carcinomas. Oncogene 27: 5267-5276, 2008.
12. Yamaji H, Iizasa T, Koh E, Suzuki M, Otsuji M, Chang H, et al: Correlation between interleukin 6 production and tumor proliferation in non-small cell lung cancer. Cancer Immunol Immunother 53: 786-792, 2004.
13. Suzuki M, Sunaga N, Shames DS, Toyooka S, Gazdar AF and Minna JD: RNA interference-mediated knockdown of DNA methyltransferase 1 leads to promoter demethylation and gene re-expression in human lung and breast cancer cells. Cancer Res 64: 3137-3143, 2004.
14. Baba Y, Huttenhower C, Nosho K, Tanaka N, Shima K, Hazra A, et al. Epigenomic diversity of colorectal cancer indicated by LINE-1 methylation in a database of 869 tumors. Mol Cancer 9: 125, 2010.
15. Suzuki M, Shiraishi K, Eguchi A, Ikeda K, Mori T, Yoshimoto K, et al. Aberrant methylation of LINE-1, SLIT2, MAL and IGFBP7 in non-small cell lung cancer. Oncol Rep 29: 1308-1314, 2013.
16. Yoshida K, Yatabe Y, Park JY, Shimizu J, Horio Y, Matsuo K, et al. Prospective validation for prediction of gefitinib sensitivity by epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer. J Thorac Oncol 2: 22-28, 2007.
17. Moses LE, Shapiro D and Littenberg B: Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations. Stat Med 12: 1293-1316, 1993.
18. Hambleton S, Salem S, Bustamante J, Bigley V, Boisson-Dupuis S, Azevedo J, et al: IRF8 mutations and human dendritic-cell immunodeficiency. N Eng J Med 365: 127-138, 2011.